Tricyclic Antidepressants
Start with the big picture
Classic TCAs include amitriptyline, nortriptyline, imipramine, desipramine, clomipramine, and doxepin. They inhibit norepinephrine and serotonin reuptake, while also blocking muscarinic, alpha-1, histamine H1, and sodium-channel activity. These actions are associated with uses such as depression, neuropathic pain, migraine prevention, and selected condition-specific applications, as well as effects including anticholinergic symptoms, sedation, orthostatic hypotension, and cardiac conduction toxicity. The lesson also covers pharmacokinetics, important contraindications and interactions, and special considerations such as delayed therapeutic benefit and overdose danger. Nortriptyline and desipramine are noted for comparatively lower anticholinergic and sedative burden.
What you'll learn
- Identify classic tricyclic antidepressants and their principal reuptake mechanism.
- Relate receptor and sodium-channel blockade to characteristic adverse effects.
- Recognize clinical uses and key pharmacokinetic features of TCAs.
- Describe major contraindications, interactions, and overdose concerns.
- Explain selected considerations in treatment response and patient selection.
Continue your study
Work through the complete notes and reinforce the topic with the study tools available in the full lesson.